Shenzhen Huahong Marine Biological Medicine Co., Ltd announced that it has entered into agreement that it will receive CNY 90 million in an equity round of funding on September 2, 2021. The transaction include participation from Shenzhen BGI Marine Sci & Tech Co.Ltd CNY 30 million for 70% registered capital and JiangsuJibeier Pharmaceutical Co., Ltd conditionally agreed for CNY 60 million consisting of approximately CNY 12.9 million for registered capital for representing approximately 30% and approximately CNY 47.1 million for capital reserve.